Here are five points:
1. The low profile SPHYNX device is designed for implantation via the antero-lateral approach to treat thoraco-lumbar instabilities.
2. The system is also indicated to treat spinal fractures, vertebral tumors and secondary instabilities of the thoracic and thoraco-lumbar spine.
3. Surgeons can use the system with Eden Spine’s proprietary corpectomy device, the GIZA implant.
4. The GIZA implant is designed to replace and fuse a collapsed, damaged or unstable vertebral body due to a tumor or fracture.
5. Eden Spine is a privately held organization focusing on spinal technologies.
More articles on devices:
6 ways Google’s Verily is making strides in the healthcare industry
Johnson & Johnson reports 2016 Q1 results; $17.5B in sales — 10 highlights
K2M’s CASCADIA interbody systems receive FDA clearance: 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
